All systems ‘GO’ for launch of PRS Global Open

Pamela Norton
04/08/2013 at 2:00PM

The first selection of articles for Plastic and Reconstructive Surgery Global Open (PRS GO) - the new open-access (OA) companion journal to PRS - are slated to debut in early April at As an OA journal, PRS GO is published exclusively online with no subscription fees, making its content permanently available at no cost to everyone with Internet access. ASPS launched PRS GO as a companion to its flagship journal, PRS, due to the continued growth of the "white journal" and the funding requirements of some granting institutions, and to meet the needs of the international community of plastic surgeons.

Key factors differentiating PRS GO's OA model from traditional publications include:

  • A subscription is not required to access the content
  • Production costs of accepted articles are covered through an article-processing charge that is paid by authors, funders, institutions, grants, etc.
  • Authors retain the copyright to their published materials
  • All requirements by research-funding agencies requiring OA publication of study results are fulfilled
  • The time from manuscript acceptance to publication is very short (approximately five-six weeks)
  • All articles are published online

Each submission to PRS GO undergoes the same strict peer-review process used by PRS. Since the journal began accepting submissions in late January, PRS GO has received dozens of manuscripts from authors worldwide, including original articles, special topics, case reports and viewpoints. The first collection of PRS GO content ranges from free flaps to fillers, and new articles will be published on as soon as they are accepted and processed. On a regular basis, older content will be organized into online "issues" or compendia that are permanently available, searchable and easily accessed.

There are a number of requirements for any journal to become indexed by PubMed and to receive an impact factor. PRS GO will apply for both as soon as it is eligible to do so.

A companion journal
There are several areas in which PRS GO complements PRS by providing greater publishing opportunities for articles that fall into the following categories:

  • Specialized fields: Some extremely interesting studies have sound scientific bases but do not affect a broad audience of plastic surgeons. In PRS GO, a case report about a rare but difficult trauma, a study in a highly specialized patient population and information on a technique that would be utilized by a relatively small percentage of surgeons can all be published.
  • Confirmatory studies: Many studies do not provide completely novel information; instead, they confirm the accuracy and importance of previously reported data. The results of these studies are very important, as they ensure accuracy, clarify methods and corroborate recommendations. There's room within PRS GO to publish these studies, setting the stage for widespread dissemination and application.
  • Preliminary findings: Follow-up of less than one year and smaller patient populations often keep the results of a study from being published in a traditional journal. However, PRS GO is an ideal avenue to report scientifically strong preliminary findings that will encourage future research.
  • History of the field: Historical perspectives on the growth of plastic surgery are always useful; however, they are less and less likely to be printed in a traditional journal. With PRS GO, papers recording the history of the field and the important lessons to be learned from its pioneers are welcome.

Global editorial board
As an official organ of ASPS, PRS GO has many advantages not often seen with newly launched journals, including:

  • An editorial board of more than 120 plastic surgeons and researchers, with a strong international presence (roughly 50 percent) to ensure worldwide impact
  • Easy online submission through Enkwell, which has step-by-step instructions and helpful author information
  • An editorial team with extensive experience led by Editor-in-Chief Rod Rohrich, MD, and co-editor James Stuzin, MD

To access PRS GO content, go to To submit articles to PRS or PRS GO, go to